EXPLORE THE SCIENCE
TL;DR: A 2026 study in Neuropsychopharmacology found that 30 mg 2C-B produced acute subjective effects in healthy adults that were similar in overall intensity to 125 mg MDMA, shorter and less distressing than 25 mg psilocybin, and less cardiovascularly stimul…
Read article
TL;DR: A 2026 Scientific Reports study of 6,805 English-language media reports found that psychedelic-treatment coverage for depression and PTSD used more positive tone than antidepressant coverage, while antidepressant coverage used more risk and negative-emo…
Read article
Borderline personality disorder (BPD) is a serious and complex psychiatric illness impacting 1-2% of the general population. Despite available treatments, many patients continue to struggle with suicidal behavior, emotional dysregulation, and impaired interper…
Read article
A new study provides preliminary evidence that MDMA-assisted therapy may help reduce alcohol use in people with severe PTSD. Key facts: MDMA-assisted therapy was tested in a phase 3 clinical trial for treating severe PTSD. Participants were allowed to have mil…
Read article
A new study reveals that the recreational drugs MDMA (also known as ecstasy or molly) and methamphetamine can increase feelings of connection and closeness with strangers during conversations. Key Facts: MDMA and methamphetamine were tested on separate groups…
Read article
Recreational drug use is constantly evolving, with new substances emerging and old drugs being used in new ways. This can pose risks, especially for the developing adolescent brain. Key Facts: Use of designer opioids like fentanyl is skyrocketing, causing a ri…
Read article